Author

Alex v. Vliet

Observed names: Alex Vliet, Alex van Vliet, M. Alexandra C. C. van Vliet, van Vliet, Alex

Institutions: The Netherlands Cancer Institute, Oncode Institute

Observed institutions: The Netherlands Cancer Institute, Oncode Institute, European Molecular Biology Laboratory

ORCID: 0000-0001-9399-2894

Observed ORCIDs: 0000-0001-9399-2894, 0000-0003-4729-4379

OpenAlex ID: A5073289554

Single-cell analysis of structural variations and complex rearrangements with tri-channel processing

2019 · Ashley D. Sanders, Sascha Meiers, et al. · Nature Biotechnology · 97

Ubiquitin ligase STUB1 destabilizes IFNγ-receptor complex to suppress tumor IFNγ signaling

2022 · Georgi Apriamashvili, David W. Vredevoogd, et al. · Nature Communications · 58

SERPINB9 is commonly amplified and high expression in cancer cells correlates with poor immune checkpoint blockade response

2022 · Sofía Ibáñez-Molero, Alex van Vliet, et al. · OncoImmunology · 39

An adverse tumor-protective effect of IDO1 inhibition

2023 · Juliana C.N. Kenski, Xinyao Huang, et al. · Cell Reports Medicine · 33

Multimodal stimulation screens reveal unique and shared genes limiting T cell fitness

2024 · Chun-Pu Lin, Pierre L. Levy, et al. · Cancer Cell · 19

Categorizing immunotherapy resistance mechanisms in non-small cell lung cancer: how can we perform better?

2025 · Daphne van der Geest, Alex van Vliet, et al. · Journal for ImmunoTherapy of Cancer · 8

The Elongin BC Complex Negatively Regulates AXL and Marks a Differentiated Phenotype in Melanoma

2023 · Sebastiaan M. Schieven, Joleen J.H. Traets, et al. · Molecular Cancer Research · 8

TMED inhibition suppresses cell surface PD-1 expression and overcomes T cell dysfunction

2024 · David W Vredevoogd, Georgi Apriamashvili, et al. · Journal for ImmunoTherapy of Cancer · 6

Cytidine diphosphate diacylglycerol synthase 2 is a synthetic lethal target in mesenchymal-like cancers

2025 · Tim Arnoldus, Alex van Vliet, et al. · Nature Genetics · 5

Cancer cell-intrinsic rewiring of the colorectal cancer secretome

2026 · Maartje Witsen, Theodoros Foskolos, et al. · iScience

Figure S7 from The Elongin BC Complex Negatively Regulates AXL and Marks a Differentiated Phenotype in Melanoma

2025 · Sebastiaan M. Schieven, Joleen J.H. Traets, et al.

Figure S5 from The Elongin BC Complex Negatively Regulates AXL and Marks a Differentiated Phenotype in Melanoma

2025 · Sebastiaan M. Schieven, Joleen J.H. Traets, et al.

Figure S3 from The Elongin BC Complex Negatively Regulates AXL and Marks a Differentiated Phenotype in Melanoma

2025 · Sebastiaan M. Schieven, Joleen J.H. Traets, et al.

Supplementary Figure Legends from The Elongin BC Complex Negatively Regulates AXL and Marks a Differentiated Phenotype in Melanoma

2025 · Sebastiaan M. Schieven, Joleen J.H. Traets, et al.

Figure S6 from The Elongin BC Complex Negatively Regulates AXL and Marks a Differentiated Phenotype in Melanoma

2025 · Sebastiaan M. Schieven, Joleen J.H. Traets, et al.

Figure S4 from The Elongin BC Complex Negatively Regulates AXL and Marks a Differentiated Phenotype in Melanoma

2025 · Sebastiaan M. Schieven, Joleen J.H. Traets, et al.

Figure S1 from The Elongin BC Complex Negatively Regulates AXL and Marks a Differentiated Phenotype in Melanoma

2025 · Sebastiaan M. Schieven, Joleen J.H. Traets, et al.

Figure S2 from The Elongin BC Complex Negatively Regulates AXL and Marks a Differentiated Phenotype in Melanoma

2025 · Sebastiaan M. Schieven, Joleen J.H. Traets, et al.

Intratumoral Heterogeneity in Ngfr+ Melanoma Subpopulations Shapes Immune Evasion and Immunotherapy Resistance

2025 · Daniel Peeper, Sebastiaan Schieven, et al. · Research Square

Abstract B001: Cytidine diphosphate diacylglycerol synthase 2 is a synthetic lethal target in mesenchymal cancers

2024 · Tim Arnoldus, Alex van Vliet, et al. · Molecular Cancer Therapeutics

Abstract PR009: Cytidine diphosphate diacylglycerol synthase 2 is a synthetic lethal target in mesenchymal cancers

2024 · Tim Arnoldus, Alex van Vliet, et al. · Molecular Cancer Therapeutics

Data from The Elongin BC Complex Negatively Regulates AXL and Marks a Differentiated Phenotype in Melanoma

2023 · Sebastiaan M. Schieven, Joleen J.H. Traets, et al.

Data from The Elongin BC Complex Negatively Regulates AXL and Marks a Differentiated Phenotype in Melanoma

2023 · Sebastiaan M. Schieven, Joleen J.H. Traets, et al.

Figure S3 from The Elongin BC Complex Negatively Regulates AXL and Marks a Differentiated Phenotype in Melanoma

2023 · Sebastiaan M. Schieven, Joleen J.H. Traets, et al.

Figure S5 from The Elongin BC Complex Negatively Regulates AXL and Marks a Differentiated Phenotype in Melanoma

2023 · Sebastiaan M. Schieven, Joleen J.H. Traets, et al.

Works count: 59

Citation count: 274

H-index: 7

I10-index: 5